![Renee Leck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Renee Leck
Public Communications Contact chez
Thrust Strategic Communications
Profil
Renee T.
Leck is MD-Investor Relations & Communications at Thrust Strategic Communications since 2024.
Formerly, Ms. Leck was Director-Investor Relations at Orchard Therapeutics Plc from 2019 to 2023 and Senior Manager-Investor Relations at Agios Pharmaceuticals, Inc. from 2015 to 2018.
Postes actifs de Renee Leck
| Sociétés | Poste | Début |
|---|---|---|
Thrust Strategic Communications
 Thrust Strategic Communications Investment ManagersFinance Provides financing planning and strategic communication for life science companies | Public Communications Contact | 01/01/2024 |
Anciens postes connus de Renee Leck
| Sociétés | Poste | Fin |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Investor Relations Contact | 01/07/2023 |
| AGIOS PHARMACEUTICALS, INC. | Public Communications Contact | 01/12/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Thrust Strategic Communications
Thrust Strategic Communications Investment ManagersFinance Provides financing planning and strategic communication for life science companies | Finance |
